Li Kang Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019
August 05, 2019 at 02:03 pm EDT
Share
Li Kang Biomedical Co., Ltd. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was TWD 130.951 million compared to TWD 159.819 million a year ago. Operating income was TWD 24.286 million compared to TWD 33.739 million a year ago. Net income was TWD 20.803 million compared to TWD 23.720 million a year ago. Basic earnings per share was TWD 0.94 compared to TWD 1.07 a year ago.
For the half year, total revenue was TWD 246.705 million compared to TWD 265.315 million a year ago. Operating income was TWD 45.754 million compared to TWD 51.902 million a year ago. Net income was TWD 38.263 million compared to TWD 43.396 million a year ago. Basic earnings per share was TWD 1.72 compared to TWD 1.95 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
